C 37
Pill imprint C 37 has been identified as Stavudine 40 mg.
Stavudine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Stavudine 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Stavudine Images
- Imprint:
-
C
37 - Strength:
- 40 mg
- Color:
- Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
sodium starch glycolate type A potato
lactose anhydrous
magnesium stearate
gelatin
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
ferric oxide red
ferrosoferric oxide
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0047
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0460 | Amerisource Health Services |
| 59762-1193 | Greenstone LLC |
Note: Inactive ingredients may vary.
Advertisement
More Stavudine resources
- Stavudine (Wolters Kluwer)
- Stavudine Solution (Wolters Kluwer)
- stavudine (Cerner Multum)
- Zerit Pediatrics (Micromedex) - Includes Dosage Information
- stavudine (Micromedex) - Includes Dosage Information
- Stavudine (AHFS DI)
- Stavudine Capsules (FDA)
- Stavudine Oral Solution (FDA)
- Stavudine (Wolters Kluwer)
Search Again
